Literature DB >> 15778708

Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.

Paola Sebastiani1, Marco F Ramoni, Vikki Nolan, Clinton T Baldwin, Martin H Steinberg.   

Abstract

Sickle cell anemia (SCA) is a paradigmatic single gene disorder caused by homozygosity with respect to a unique mutation at the beta-globin locus. SCA is phenotypically complex, with different clinical courses ranging from early childhood mortality to a virtually unrecognized condition. Overt stroke is a severe complication affecting 6-8% of individuals with SCA. Modifier genes might interact to determine the susceptibility to stroke, but such genes have not yet been identified. Using Bayesian networks, we analyzed 108 SNPs in 39 candidate genes in 1,398 individuals with SCA. We found that 31 SNPs in 12 genes interact with fetal hemoglobin to modulate the risk of stroke. This network of interactions includes three genes in the TGF-beta pathway and SELP, which is associated with stroke in the general population. We validated this model in a different population by predicting the occurrence of stroke in 114 individuals with 98.2% accuracy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778708      PMCID: PMC2896308          DOI: 10.1038/ng1533

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  24 in total

1.  Mass spectrometry of single-stranded restriction fragments captured by an undigested complementary sequence.

Authors:  N H Chiu; K Tang; P Yip; A Braun; H Koster; C R Cantor
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  Segregation at three loci explains familial and population risk in Hirschsprung disease.

Authors:  Stacey B Gabriel; Rémi Salomon; Anna Pelet; Misha Angrist; Jeanne Amiel; Myriam Fornage; Tania Attié-Bitach; Jane M Olson; Robert Hofstra; Charles Buys; Julie Steffann; Arnold Munnich; Stanislas Lyonnet; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2002-04-15       Impact factor: 38.330

3.  A Bayesian networks approach for predicting protein-protein interactions from genomic data.

Authors:  Ronald Jansen; Haiyuan Yu; Dov Greenbaum; Yuval Kluger; Nevan J Krogan; Sambath Chung; Andrew Emili; Michael Snyder; Jack F Greenblatt; Mark Gerstein
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

Review 4.  Mathematical multi-locus approaches to localizing complex human trait genes.

Authors:  Josephine Hoh; Jurg Ott
Journal:  Nat Rev Genet       Date:  2003-09       Impact factor: 53.242

5.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

6.  Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart.

Authors:  C B Brown; A S Boyer; R B Runyan; J V Barnett
Journal:  Science       Date:  1999-03-26       Impact factor: 47.728

7.  Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease.

Authors:  R E Ware; S A Zimmerman; W H Schultz
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

Review 8.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease.

Authors:  David Botstein; Neil Risch
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

Review 9.  Sickle cell crisis and endothelin antagonists.

Authors:  Allan D Angerio; Nicole D Lee
Journal:  Crit Care Nurs Q       Date:  2003 Jul-Sep

10.  Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease.

Authors:  James G Taylor; Delia C Tang; Sharon A Savage; Susan F Leitman; Seth I Heller; Graham R Serjeant; Griffin P Rodgers; Stephen J Chanock
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

View more
  106 in total

1.  Biomarkers for early detection of sickle nephropathy.

Authors:  Nambirajan Sundaram; Michael Bennett; Jamie Wilhelm; Mi-Ok Kim; George Atweh; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

Review 2.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

3.  Genetic predictors for stroke in children with sickle cell anemia.

Authors:  Jonathan M Flanagan; Denise M Frohlich; Thad A Howard; William H Schultz; Catherine Driscoll; Ramamoorthy Nagasubramanian; Nicole A Mortier; Amy C Kimble; Banu Aygun; Robert J Adams; Ronald W Helms; Russell E Ware
Journal:  Blood       Date:  2011-04-22       Impact factor: 22.113

4.  Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis.

Authors:  Gabriela Cesarman-Maus; Carlos Cantú-Brito; Fernando Barinagarrementeria; Rosario Villa; Elba Reyes; Jorge Sanchez-Guerrero; Katherine A Hajjar; Ethel Garcia Latorre
Journal:  Stroke       Date:  2010-12-30       Impact factor: 7.914

Review 5.  Genetics of stroke.

Authors:  Jin-min Guo; Ai-jun Liu; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

Review 6.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

7.  Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Authors:  Clinton Baldwin; Vikki G Nolan; Diego F Wyszynski; Qian-Li Ma; Paola Sebastiani; Stephen H Embury; Alice Bisbee; John Farrell; Lindsay Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

Review 8.  Blood biologic markers of stroke: improved management, reduced cost?

Authors:  Alison E Baird
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

9.  Bayesian graphical models for genomewide association studies.

Authors:  Claudio J Verzilli; Nigel Stallard; John C Whittaker
Journal:  Am J Hum Genet       Date:  2006-05-30       Impact factor: 11.025

Review 10.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.